Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines
Kellie D. Nance, Jordan L. Meier
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 748-756
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 414
Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 398
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 348
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
Julian Stumpf, Torsten Siepmann, Tom H. Lindner, et al.
The Lancet Regional Health - Europe (2021) Vol. 9, pp. 100178-100178
Open Access | Times Cited: 291
Principles for designing an optimal mRNA lipid nanoparticle vaccine
Edo Kon, Uri Elia, Dan Peer
Current Opinion in Biotechnology (2021) Vol. 73, pp. 329-336
Open Access | Times Cited: 188
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 181
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 121
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 92
Decoding pseudouridine: an emerging target for therapeutic development
Jonas Cerneckis, Qi Cui, Chuan He, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 522-535
Open Access | Times Cited: 91
Quantitative profiling of pseudouridylation landscape in the human transcriptome
Meiling Zhang, Zhe Jiang, Yichen Ma, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1185-1195
Open Access | Times Cited: 83
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 81
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 77
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1192-1204
Closed Access | Times Cited: 77
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 51
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods
Andrew Webb, Emma N. Welbourne, Caroline A. Evans, et al.
Journal of Chromatography A (2025), pp. 465724-465724
Closed Access | Times Cited: 3
Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
Kai K. Ewert, Pablo Scodeller, Lorena Simón‐Gracia, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1365-1365
Open Access | Times Cited: 93
The epitranscriptome toolbox
Sharon Moshitch-Moshkovitz, Dan Dominissini, Gideon Rechavi
Cell (2022) Vol. 185, Iss. 5, pp. 764-776
Open Access | Times Cited: 69
Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective
Abid Haseeb, Omar Solyman, Mokhtar Mohamed Ibrahim Abushanab, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 342-342
Open Access | Times Cited: 66
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Albert Liu, Xiao Wang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 58
Exploring the epitranscriptome by native RNA sequencing
Oguzhan Begik, John S. Mattick, Eva Maria Novoa
RNA (2022) Vol. 28, Iss. 11, pp. 1430-1439
Open Access | Times Cited: 48
Epitranscriptome: Review of Top 25 Most-Studied RNA Modifications
Viktoriia A. Arzumanian, Georgii Dolgalev, Ilya Y. Kurbatov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13851-13851
Open Access | Times Cited: 47
Vaccine-Associated Uveitis after COVID-19 Vaccination
Rohan Bir Singh, Uday Pratap Singh Parmar, Francesca Kahale, et al.
Ophthalmology (2022) Vol. 130, Iss. 2, pp. 179-186
Open Access | Times Cited: 43
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
Dimitra S. Mouliou, Efthimios Dardiotis
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1555-1555
Open Access | Times Cited: 40
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top